Hirtz Christophe, Vialaret Jerome, Nouadje Georges, Schraen Susanna, Benlian Pascale, Mary Sandrine, Philibert Pascal, Tiers Laurent, Bros Pauline, Delaby Constance, Gabelle Audrey, Lehmann Sylvain
CHRU de Montpellier, Hôpital St Eloi Université de Montpellier, INSERM U1183, IRMB, Laboratoire de Biochimie Protéomique Clinique, Montpellier, France.
SEBIA, 91008 Evry, France.
Clin Chim Acta. 2016 Feb 15;454:33-8. doi: 10.1016/j.cca.2015.12.020. Epub 2015 Dec 19.
Apolipoprotein E (Apo E) is a 36 Kda glycoprotein involved in lipid transport. It exists in 3 major isoforms: E2, E3 and E4. ApoE status is known to be a major risk factor for late-onset Alzheimer's and cardiovascular diseases. Genotyping is commonly used to obtain ApoE status but can show technical issues with ambiguous determinations. Phenotyping can be an alternative, not requiring genetic material. We evaluated the ability to accurately type ApoE isoforms by 2 phenotyping tests in comparison with genotyping.
Two phenotyping techniques were used: (1) LC-MS/MS detection of 4 ApoE specific peptides (6490 Agilent triple quadripole): After its denaturation, serum was either reduced and alkylated, or only diluted, and then trypsin digested. Before analysis, desalting, evaporation and resuspension were performed. (2) Isoelectric focusing and immunoprecipitation: serum samples were neuraminidase digested, delipidated and electrophoresed on Hydragel ApoE (Sebia agarose gel) using Hydrasys 2 Scan instrument (Sebia, Lisses, France). ApoE isoforms bands were directly immunofixed in the gel using a polyclonal anti human ApoE antibody. Then, incubation of the gel with HRP secondary antibody followed by TTF1/TTF2 substrate allowed the visualization of ApoE bands. The results of the two techniques were compared to genotyping.
Sera from 35 patients previously genotyped were analyzed with the 2 phenotyping techniques. 100% concordance between both phenotyping assays was obtained for the tested phenotypes (E2/E2, E2/E3, E2/E4, E3/E3, E3/E4, E4/E4). When compared to genotyping, 3 samples were discordant. After reanalyzing them by both phenotyping tests and DNA sequencing, 2/3 discrepancies were confirmed. Those can be explained by variants or rare ApoE alleles or by unidentified technical issues. 102 additional samples were then tested on LC-MS/MS only and compared to genotyping. The data showed 100% concordance.
Our 2 phenotyping methods represent a valuable alternative to genotyping. LC-MS/MS has the advantage of being fully specific, with identification of the different isoforms and can be considered as a reference method. Sebia isofocusing technique was concordant with LC-MS/MS. Plus, it is a rapid, semi-automated assay that can be easily implemented in clinical laboratories.
载脂蛋白E(Apo E)是一种参与脂质运输的36 kDa糖蛋白。它以三种主要异构体形式存在:E2、E3和E4。已知ApoE状态是晚发型阿尔茨海默病和心血管疾病的主要危险因素。基因分型常用于获取ApoE状态,但可能存在技术问题,如判定不明确。表型分型可以作为一种替代方法,不需要遗传物质。我们评估了两种表型分型测试与基因分型相比准确鉴定ApoE异构体的能力。
使用了两种表型分型技术:(1)通过液相色谱-串联质谱法(LC-MS/MS)检测4种ApoE特异性肽段(6490安捷伦三重四极杆):血清变性后,要么进行还原和烷基化处理,要么仅进行稀释,然后用胰蛋白酶消化。分析前进行脱盐、蒸发和重悬。(2)等电聚焦和免疫沉淀:血清样本经神经氨酸酶消化、脱脂后,使用Hydrasys 2 Scan仪器(法国利塞斯的Sebia公司)在Hydragel ApoE(Sebia琼脂糖凝胶)上进行电泳。使用多克隆抗人ApoE抗体将ApoE异构体条带直接免疫固定在凝胶中。然后,将凝胶与辣根过氧化物酶二抗孵育,随后加入TTF1/TTF2底物,使ApoE条带可视化。将这两种技术的结果与基因分型结果进行比较。
用这两种表型分型技术对35例先前已进行基因分型的患者的血清进行了分析。对于所测试的表型(E2/E2、E2/E3、E2/E4、E3/E3、E3/E4、E4/E4),两种表型分型测定之间的一致性为100%。与基因分型相比,有3个样本不一致。通过两种表型分型测试和DNA测序对它们进行重新分析后,2/3的差异得到确认。这些差异可以用变异体或罕见的ApoE等位基因或不明技术问题来解释。然后仅对另外102个样本进行了LC-MS/MS测试,并与基因分型进行比较。数据显示一致性为100%。
我们的两种表型分型方法是基因分型的一种有价值的替代方法。LC-MS/MS具有完全特异性的优点,能够鉴定不同的异构体,可被视为参考方法。Sebia等电聚焦技术与LC-MS/MS结果一致。此外,它是一种快速、半自动的检测方法,可在临床实验室轻松实施。